1. Is a methodology available that accurately measures the cost of an FDG-PET study?

   • Bruno Krug
   • Anne Sophie Pirson
   • Thierry Vander Borght

   Editorial 08 December 2006 Pages: 625 - 627

2. PET/CT in paediatrics: it is time to increase its use!

   • Isabel Roca
   • Marc Simó
   • Josep Sanchez de Toledo

   Editorial 18 January 2007 Pages: 628 - 629

3. The incremental value of ¹⁸F-FDG PET/CT in paediatric malignancies

   • Zvi Bar-Sever
   • Zohar Keidar
   • Ora Israel

   Original article 18 October 2006 Pages: 630 - 637

   

4. Efficacy of ^99mTc pertechnetate and ¹³¹I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo

   • Meike L. Schipper
   • Christoph G. U. Riese
   • Thomas M. Behr

   Original article 08 December 2006 Pages: 638 - 650

   

5. 1-[¹¹C]-acetate PET imaging in head and neck cancer—a comparison with ¹⁸F-FDG-PET: implications for staging and radiotherapy planning

   • Aijun Sun
   • Jens Sörensen
   • Silvia Johansson

   Original Article 05 December 2006 Pages: 651 - 657

   

6. Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

   • G. Mangili
   • M. Picchio
   • F. Fazio

   Original Article 20 December 2006 Pages: 658 - 666

   

7. Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [¹¹C]PE2I

   • H. Umesha Shetty
   • Sami S. Zoghbi
   • Victor W. Pike

   Original article 10 November 2006 Pages: 667 - 678

   

8. Quantification of adenosine A_2A receptors in the human brain using [¹¹C]TMSX and positron emission tomography

   • Mika Naganawa
   • Yuichi Kimura
   • Kiichi Ishiwata

   Original Article 15 December 2006 Pages: 679 - 687

   

9. In vivo assessment of [¹¹C]MRB as a prospective PET ligand for imaging the norepinephrine transporter

   • Alin J. Severance
   • Matthew S. Milak
   • Ramin V. Parsey

   Short Communication 19 December 2006 Pages: 688 - 693

   

10. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin

    • Chantal P. Bleeker-Rovers
    • Fidel J. Vos
    • Wim J. G. Oyen

    Original Article 14 December 2006 Pages: 694 - 703

    

11. Diagnostic value of ¹⁸F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis

    • Anna Hartmann
    • Karim Eid
    • Katrin D. M. Stumpe

    Original Article 29 November 2006 Pages: 704 - 714

    

12. Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells

    • Bernd Nowak
    • Christian Weber
    • Ulrich Buell

    Original article 10 November 2006 Pages: 715 - 721

    

13. Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the ^99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

    • Torun Engfeldt
    • Anna Orlova
    • Vladimir Tolmachev

    Original article 05 December 2006 Pages: 722 - 733

    

14. Assessment of insulin resistance in fructose-fed rats with ¹²⁵I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport

    • Pascale Perret
    • Lotfi Slimani
    • Catherine Ghezzi

    Original article 15 December 2006 Pages: 734 - 744

    

15. In vivo imaging of integrin ανβ₃ expression using fluorescence-mediated tomography

    • Angelika von Wallbrunn
    • Carsten Höltke
    • Christoph Bremer

    Molecular imaging 28 November 2006 Pages: 745 - 754

    

16. FDG small animal PET permits early detection of malignant cells in a xenograft murine model

    • Cristina Nanni
    • Korinne Di Leo
    • Stefano Fanti

    Molecular Imaging 08 December 2006 Pages: 755 - 762

    

17. Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate

    • Edgar J. Rolleman
    • Flavio Forrer
    • Marion de Jong

    Original Article 05 December 2006 Pages: 763 - 771

    

18. Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

    • B. Brans
    • L. Bodei
    • J. Tennvall

    Review article Open access 01 February 2007 Pages: 772 - 786

    

19. The emergence of MRI and MSCT cardiac imaging: nuclear cardiology is not the only actor on the stage

    • Giovanni Lucignani

    Focus on... 30 March 2007 Pages: 787 - 793

20. International Atomic Energy Agency: Nuclear medicine resources manual. 2006. IAEA, Vienna, 532 pp., 55 illustrations. €65.00. ISBN 92-0-107504-9.

    • Andrea Soricelli

    Book review 29 December 2006 Pages: 794 - 795

21. The new EANM paediatric dosage card

    • M. Lassmann
    • L. Biassoni
    • for the EANM Dosimetry and Paediatrics Committees

    Special contribution 04 April 2007 Pages: 796 - 798

22. Michael E. Phelps (ed) PET: physics, instrumentation and scanners. Springer, New York, 2006, 130 pp, 77 illustrations. Hardcover. $59.95. ISBN-10: 0-387-32302-3, ISBN-13: 978-0-387-32302-2

    • Mario Quarantelli
    • Anna Prinster

    Book Review 23 January 2007 Pages: 799 - 799

23. Society communications

    Society communications 06 April 2007 Pages: 800 - 805

24. AIPES Conference, Brussels, 21 November 2006

    Society communications 05 April 2007 Pages: 806 - 807

    

25. Erratum to Abstracts of the Annual Congress of the EANM, Athens, Greece, 2006

    • George P. Gerasimou
    • Dimitrios E. Antoniou

    Erratum 28 March 2007 Pages: 808 - 811

26. Neuroendocrine tumour of the mediastinum: fusion of ¹⁸F-FDG and ⁶⁸Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation

    • C. von Falck
    • A. R. Boerner
    • W. H. Knapp

    Image of the month 23 January 2007 Pages: 812 - 812

27. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings

    • K. Strobel
    • H. C. Steinert
    • S. J. Stöckli

    Image of the month 16 January 2007 Pages: 813 - 813